• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在瑞典医疗保健系统中多发性硬化症的接触模式和成本:一项基于人群的定量研究。

Contact patterns and costs of multiple sclerosis in the Swedish healthcare system-A population-based quantitative study.

机构信息

Section of Neurology, Department of Internal Medicine, County Hospital Ryhov, Jönköping, Sweden.

Division of Neurobiology, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.

出版信息

Brain Behav. 2022 Jun;12(6):e2582. doi: 10.1002/brb3.2582. Epub 2022 May 5.

DOI:10.1002/brb3.2582
PMID:35511113
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9226803/
Abstract

BACKGROUND

The burden of disease for persons with multiple sclerosis (MS) and society is changing due to new treatments. Knowledge about the total need for care is necessary in relation to changing needs and new service models.

OBJECTIVE

The aim of this study was to describe the contact patterns for MS patients, calculate costs in health care, and create meaningful subgroups to analyze contact patterns.

METHODS

All patients diagnosed with MS at Ryhov Hospital were included. All contacts in the region from January 1, 2018, until September 30, 2019, were retrieved from the hospital administrative system. Data about age, sex, contacts, and diagnosis were registered. The cost was calculated using case costing, and costs for prescriptions were calculated from medical files.

RESULTS

During the 21-month period, patients (n = 305) had 9628 contacts and 7471 physical visits, with a total cost of $7,766,109. Seventeen percent of the patients accounted for 48% of the visits. The median annual cost was $7386 in the group with 10 or fewer visits, compared to $22,491 in patients with more than 50 visits.

CONCLUSION

There are considerable differences in the utilization of care and cost between patients with MS in an unselected population, meaning that the care needs to be better customized to each patient's demands.

摘要

背景

由于新的治疗方法,多发性硬化症(MS)患者和社会的疾病负担正在发生变化。了解整体护理需求对于不断变化的需求和新的服务模式是必要的。

目的

本研究旨在描述 MS 患者的就诊模式,计算医疗保健成本,并创建有意义的亚组来分析就诊模式。

方法

所有在 Ryhov 医院诊断为 MS 的患者均纳入研究。从医院管理系统中检索 2018 年 1 月 1 日至 2019 年 9 月 30 日期间该地区的所有就诊信息。记录患者的年龄、性别、就诊次数和诊断信息。使用病例成本法计算成本,从医疗记录中计算处方成本。

结果

在 21 个月的时间里,305 名患者共就诊 9628 次,其中 7471 次为实体就诊,总费用为 7766109 美元。17%的患者占就诊次数的 48%。就诊次数在 10 次以下的患者的年平均费用为 7386 美元,而就诊次数超过 50 次的患者的年平均费用为 22491 美元。

结论

在未选择的 MS 患者人群中,护理的利用和成本存在显著差异,这意味着需要根据每位患者的需求更好地定制护理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f25d/9226803/ba4830655b4d/BRB3-12-e2582-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f25d/9226803/32455ee537c6/BRB3-12-e2582-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f25d/9226803/ba4830655b4d/BRB3-12-e2582-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f25d/9226803/32455ee537c6/BRB3-12-e2582-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f25d/9226803/ba4830655b4d/BRB3-12-e2582-g002.jpg

相似文献

1
Contact patterns and costs of multiple sclerosis in the Swedish healthcare system-A population-based quantitative study.在瑞典医疗保健系统中多发性硬化症的接触模式和成本:一项基于人群的定量研究。
Brain Behav. 2022 Jun;12(6):e2582. doi: 10.1002/brb3.2582. Epub 2022 May 5.
2
Impact on healthcare resource utilization of multiple sclerosis in Spain.西班牙多发性硬化症对医疗资源利用的影响。
BMC Health Serv Res. 2017 Dec 29;17(1):854. doi: 10.1186/s12913-017-2807-x.
3
Healthcare resource use and costs of multiple sclerosis patients in Germany before and during fampridine treatment.德国多发性硬化症患者在服用氨吡啶治疗前及治疗期间的医疗资源使用情况和费用
BMC Neurol. 2017 Mar 27;17(1):62. doi: 10.1186/s12883-017-0844-z.
4
Perspectives in multiple sclerosis health care: special focus on the costs of multiple sclerosis.多发性硬化症医疗保健的视角:特别关注多发性硬化症的成本
Autoimmun Rev. 2006 Oct;5(8):511-6. doi: 10.1016/j.autrev.2006.02.001. Epub 2006 Mar 10.
5
Health care utilization before and after intensive care unit admission in multiple sclerosis.重症监护病房收治前后多发性硬化症患者的医疗服务利用情况
Mult Scler Relat Disord. 2015 Jul;4(4):296-303. doi: 10.1016/j.msard.2015.05.010. Epub 2015 May 30.
6
The economic cost of multiple sclerosis in Sweden in 1994.1994年瑞典多发性硬化症的经济成本。
Pharmacoeconomics. 1998 May;13(5 Pt 2):597-606. doi: 10.2165/00019053-199813050-00012.
7
Economic burden of multiple sclerosis in France estimated from a regional medical registry and national sick fund claims.基于区域医疗登记和国家疾病基金索赔估计法国多发性硬化症的经济负担。
Mult Scler Relat Disord. 2019 Nov;36:101396. doi: 10.1016/j.msard.2019.101396. Epub 2019 Sep 10.
8
Health care services and disease modifying therapies use in community-based multiple sclerosis patients: Evolution from 2013 to 2015 and demographic characteristics.社区多发性硬化症患者的医疗保健服务及疾病改善疗法的应用:2013年至2015年的演变及人口统计学特征
Presse Med. 2019 Jan;48(1 Pt 1):e1-e19. doi: 10.1016/j.lpm.2018.04.013. Epub 2018 Dec 7.
9
Disease modifying therapies continue to drive up health care cost among individuals with multiple sclerosis.疾病修正疗法持续推高多发性硬化症患者的医疗保健费用。
Mult Scler Relat Disord. 2019 May;30:69-75. doi: 10.1016/j.msard.2019.02.006. Epub 2019 Feb 5.
10
How much is the cost of multiple sclerosis--systematic literature review.多发性硬化症的花费是多少——系统文献综述
Przegl Epidemiol. 2013;67(1):75-9, 157-60.

引用本文的文献

1
Exploring Different Levels of Contact Frequency in Multiple Sclerosis Care.探索多发性硬化症护理中不同程度的接触频率。
Brain Behav. 2025 Jul;15(7):e70634. doi: 10.1002/brb3.70634.
2
Lived experience of persons with multiple sclerosis: A qualitative interview study.多发性硬化症患者的生活体验:一项定性访谈研究。
Brain Behav. 2023 Jul;13(7):e3104. doi: 10.1002/brb3.3104. Epub 2023 May 29.

本文引用的文献

1
Multiple sclerosis is associated with higher comorbidity and health care resource use: A population-based, case-control study in a western Mediterranean region.多发性硬化症与更高的共病率和医疗资源利用相关:一项基于人群的地中海西部地区病例对照研究。
Eur J Neurol. 2021 Dec;28(12):4124-4134. doi: 10.1111/ene.15030. Epub 2021 Aug 5.
2
The Efficacy of the Geriatric Model of Care in Emergency Housing Programs for Homeless Veterans.老年患者护理模式在无家可归退伍军人紧急住房项目中的效果。
Med Care. 2021 Apr 1;59(Suppl 2):S154-S157. doi: 10.1097/MLR.0000000000001438.
3
COproduction VALUE creation in healthcare service (CO-VALUE): an international multicentre protocol to describe the application of a model of value creation for use in systems of coproduced healthcare services and to evaluate the initial feasibility, utility and acceptability of associated system-level value creation assessment approaches.
医疗服务中的共同生产价值创造(CO-VALUE):一项国际多中心方案,旨在描述用于共同生产的医疗服务系统的价值创造模型的应用,并评估相关系统层面价值创造评估方法的初步可行性、实用性和可接受性。
BMJ Open. 2020 Oct 5;10(10):e037578. doi: 10.1136/bmjopen-2020-037578.
4
Networked health care: Rethinking value creation in learning health care systems.网络化医疗保健:重新思考学习型医疗保健系统中的价值创造。
Learn Health Syst. 2019 Dec 5;4(2):e10212. doi: 10.1002/lrh2.10212. eCollection 2020 Apr.
5
Real-World Treatment of Patients with Multiple Sclerosis per MS Subtype and Associated Healthcare Resource Use: An Analysis Based on 13,333 Patients in Germany.根据德国13333例患者分析多发性硬化症各亚型患者的真实世界治疗情况及相关医疗资源使用情况
Neurol Ther. 2020 Jun;9(1):67-83. doi: 10.1007/s40120-019-00172-5. Epub 2019 Dec 12.
6
Promoting a sense of security in everyday life-A case study of patients and professionals moving towards co-production in an atrial fibrillation "learning café".促进日常生活中的安全感——以心房颤动“学习咖啡馆”中患者和专业人员共同参与为案例的研究
Health Expect. 2019 Dec;22(6):1240-1250. doi: 10.1111/hex.12955. Epub 2019 Aug 21.
7
Multiple sclerosis.多发性硬化症。
Lancet. 2018 Apr 21;391(10130):1622-1636. doi: 10.1016/S0140-6736(18)30481-1. Epub 2018 Mar 23.
8
Clinical effectiveness and cost-effectiveness of beta-interferon and glatiramer acetate for treating multiple sclerosis: systematic review and economic evaluation.β干扰素和醋酸格拉替雷治疗多发性硬化症的临床疗效和成本效益:系统评价和经济评估。
Health Technol Assess. 2017 Sep;21(52):1-352. doi: 10.3310/hta21520.
9
Economics and Cost-Effectiveness of Multiple Sclerosis Therapies in the USA.美国多发性硬化症治疗的经济学和成本效益分析。
Neurotherapeutics. 2017 Oct;14(4):1018-1026. doi: 10.1007/s13311-017-0566-3.
10
What outcomes are associated with developing and implementing co-produced interventions in acute healthcare settings? A rapid evidence synthesis.在急性医疗环境中开发和实施共同生产的干预措施会带来哪些结果?一项快速证据综合分析。
BMJ Open. 2017 Jul 11;7(7):e014650. doi: 10.1136/bmjopen-2016-014650.